Industry Insights

  1. EU GMP Annex 1 – Navigating The Road To A Successful Annex 1 Inspection 7/17/2024

    The complexities of EU GMP Annex 1 inspections can be challenging. At an event hosted by NIBRT and Cencora PharmaLex, industry experts shared key insights and best practices for ensuring compliance.

  2. Supply Chain Security: Focus On Raw Material Variability 3/26/2020

    Qualifying suppliers, increasing capacity, implementing a supplier scorecard, and surveying suppliers' number of production lines help guarantee supply, but close attention must be paid to raw materials.

  3. Building Robust Clinical Supply Chains To Support Global Trials

    Ensuring drugs reach patients at the right time and place is crucial. Review key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.

  4. Using System Risk Structures To Evaluate COVID-19 Pandemic Risks 12/15/2021

    This article's discussion demonstrates how system risk structures (SRS) can be used to understand complex risks and how SRS might be applied to understand the very complex risk landscape of the COVID-19 pandemic. It includes analysis of risk of personal infection, risk of disease progression or spreading, risk of vaccination, and more.

  5. The Coevolution Of The Single-Use And Biopharmaceutical Industries

    Learn more about the evolution of one company's solutions for biopharmaceutical manufacturing and accelerating market entrance using single-use technology.

  6. How Clean Is Your Kitchen? Analogies Explain The Value Of Digital Solutions 3/2/2023

    Check out this analogy that could help senior IT and business leaders explain their companies IT needs in a simple, easy to understand way.

  7. Innovating During The COVID-19 Pandemic

    Pharmaceutics International, Inc., (Pii) is a premier CDMO, offering unparalleled scientific insight and depth of product knowledge, while supplying high-quality dosage forms that enhance the lives of patients worldwide. Pii provides customized and flexible solutions across several dosage forms and has experience with a broad range of compounds.

  8. How Preclinical And Nonclinical Studies Differ, And Where They Belong 1/11/2022

    Learn when should each term be used, and the appropriate timelines for preclinical and nonclinical studies within a drug development program.

  9. Speeding-Up Analysis And Fast-Tracking mRNA Development 5/13/2024

    mRNA therapeutics have the potential to address a variety of diseases, and understanding mRNA molecules and access faster analytical solutions are crucial elements for the rapid development of these therapies.

  10. The Global Market For Generic Sterile Injectables To Double In Value By 2032 5/15/2023

    According to new analysis at insightSLICE, the global generic sterile injectable market size was estimated to be $79.95 billion in 2022 and is expected to grow to reach $159 billion by 2032. What are the key factors and trends driving this growth? This author shares the key data-led insights.